Protagonist Therapeutics
(NASDAQ:PTGX)
$28.46
0[0.00%]
At close: Mar 18
$28.46
0[0.00%]
PreMarket: 4:00PM EDT

GET A REPORT ON PTGX SENT RIGHT TO YOUR INBOX

50%
Overview Rating
Speculative
Technicals Analysis
100
0100
Financials Analysis
20
0100

Protagonist Therapeutics Stock (NASDAQ:PTGX), Quotes and News Summary

Protagonist Therapeutics Stock (NASDAQ: PTGX) stock price, news, charts, stock research, profile.
Open-
Close-
Volume / Avg.0 / 758.538K
Day Range- - -
52 Wk Range13.720 - 33.340
Market Cap$1.659B
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
48
Short Interest
4.83%
Days to Cover2.65
20%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Ratings
Sep 23
1
Oct 23
2
Nov 23
0
0
0
0
0
Feb
2
Mar
1
Strong Buy
Buy
Hold
Sell
Strong Sell
About Protagonist Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary tech...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
PTGX
TWST

FAQ

Q

How do I buy Protagonist Therapeutics (PTGX) stock?

A

You can purchase shares of Protagonist Therapeutics (NASDAQ: PTGX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Protagonist Therapeutics's (PTGX) competitors?

Q

What is the target price for Protagonist Therapeutics (PTGX) stock?

A

The latest price target for Protagonist Therapeutics (NASDAQ: PTGX) was reported by HC Wainwright & Co. on Monday, March 11, 2024. The analyst firm set a price target for 38.00 expecting PTGX to rise to within 12 months (a possible 33.52% upside). 15 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Protagonist Therapeutics (PTGX)?

A

The stock price for Protagonist Therapeutics (NASDAQ: PTGX) is $28.46 last updated March 18, 2024 at 4:00 PM EDT.

Q

Does Protagonist Therapeutics (PTGX) pay a dividend?

A

There are no upcoming dividends for Protagonist Therapeutics.

Q

When is Protagonist Therapeutics (NASDAQ:PTGX) reporting earnings?

A

Protagonist Therapeutics’s Q1 earnings are confirmed for Thursday, May 2, 2024.

Q

Is Protagonist Therapeutics (PTGX) going to split?

A

There is no upcoming split for Protagonist Therapeutics.

Q

What sector and industry does Protagonist Therapeutics (PTGX) operate in?

A

Protagonist Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch